Intelligent Information Security Technology Inc. (IIST) specializes in the development of advanced PUF (Physical Unclonable Function) cybersecurity technology, chip system integration, and the comprehensive patent layout of its proprietary security technologies.
Instant NanoBiosensors Co. Ltd
Instant NanoBiosensors (INB) is an innovative precision medicine company specializing in ultra-sensitive protein-based blood tests for Alzheimer’s disease and gene-based solutions for leukemia through its INLab NGS Solution. Revolutionizing Alzheimer’s Diagnostics Leveraging our proprietary Fiber Optic Particle Plasmon Resonance (FOPPR™) technology, we provide a non-invasive, rapid, and cost-effective solution for the early detection of Alzheimer’s-related biomarkers. Our technology enhances diagnostic accuracy, accelerates drug development, and supports personalized medicine applications for medical institutions and pharmaceutical companies. INB is the only point-of-care testing (POCT) platform on the market that enables end-to-end solutions—from antibody analysis to ultra-sensitive assay development. This platform has been adopted by the EU-funded TAuimMunE (TAME) project as a key training tool for PhD researchers. Current blood biomarker diagnostic methods are often expensive, centralized, and require specialized personnel to operate. INB’s solution addresses these limitations by making early Alzheimer’s detection more accessible and affordable. Our goal is to provide a highly accessible and precise diagnostic platform that enhances patient care and therapeutic outcomes worldwide. Leukemia Precision Medicine: INLab NGS Solution In leukemia diagnostics, INB has developed a comprehensive NGS Precision Medicine Solution that streamlines the entire workflow—from sample processing to final report generation—with fully integrated instruments, reagents, and software. We have extensive experience collaborating with National Taiwan University Hospital, working closely with hematology and oncology specialists to develop clinically relevant diagnostic reagents. Our solution currently serves nearly 70% of leukemia patients in Taiwan and has also been adopted by Yale Medical Center in the United States. Key Advantages of Our Solution ✅ Enhanced Accuracy and Efficiency: Our proprietary DimerOff™ technology minimizes primer dimer formation and sequencing noise, producing cleaner, more accurate sequencing data. This significantly improves sensitivity for detecting MDS/AML-related mutations, ensures higher clinical reliability, reduces sequencing costs by more than 50%, and shortens the turnaround time to just three days. ✅ MRD Detection & MPN Monitoring: Our solution enables precise monitoring of measurable residual disease (MRD) and myeloproliferative neoplasms (MPN), supporting long-term patient management and treatment adjustments. ✅ Customizable Panels for Specific Clinical Needs: We work closely with clinicians and researchers to develop NGS panels tailored to specific research and diagnostic requirements. Our flexible approach optimizes mutation detection, enhances patient stratification, and reduces operational costs for both research and clinical applications. Through continuous innovation and strategic partnerships, INB is committed to transforming precision medicine and improving patient outcomes worldwide. We Are Seeking Partnerships With: International Distributors interested in bringing our innovative diagnostic solutions to global markets. Biotech Companies looking for co-development opportunities in assay and panel development. Pharmaceutical Companies seeking companion diagnostics solutions to support targeted drug development. Hospitals & CROs aiming to establish a comprehensive precision medicine system within their organization. Scientists & Research Institutions interested in collaborative grant applications. If you are interested in collaborating with us, we welcome the opportunity to discuss how INB’s cutting-edge solutions can support your research, clinical, and commercial objectives.
Innovative Medical Manufacturing Company
IMM is a disposable device OEM/CDMO provider located in Taiwan. We specify in plastic molding/extrusion, cleanroom manufacturing to finish sterile products. As a full-scale manufacturer we engage early at minimal cost so you can launch faster, and we both win at scale. IMM has been FDA foreign site audited couple times in the last 10 years.
Ink Total Solution
At Ink Total Solution, we are proud of our Taiwanese heritage and are dedicated to producing inks of exceptional quality and craftsmanship. Our inks are engineered to meet high standards of performance, durability, and sustainability. We offer a comprehensive selection of inks to suit various printing needs, including solvent, eco-solvent, UV-curable, dye-sublimation, DTF and compatible ink cartridges and ink bags, complete with IC or RFID chips. As a global supplier, we provide worldwide shipping via air/sea freight or express couriers, ensuring our premium inks are accessible wherever you are. Whether you are a seasoned printing professional or a business owner, we aim to be your trusted partner, providing quality, reliability, and innovative ink solutions. | At Ink Total Solution, we proudly uphold our Taiwanese heritage by producing high-quality inks with exceptional craftsmanship. Our products are designed for performance, durability, and sustainability. We offer a versatile range of inks, including solvent, eco-solvent, UV-curable, and dye-sublimation options, as well as compatible cartridges and ink bags with IC or RFID chips. As a global supplier, we provide reliable worldwide shipping via air, sea, or express delivery. Whether you’re a printing professional or a business owner, we aim to be your trusted partner, delivering consistent quality and innovative ink solutions.
Ing Tien Enterprise Co., Ltd.
Ing-Tien Enterprise, formally established in 1988, is a renowned motor vehicle parts manufacturer in Taiwan, specializing in the manufacturing of an engine overhaul pack for all major car brands. We are the most recognized designer and developer in the steel mould manufacturing field, with several decades of professional manufacturing experience. Currently, our product focus is on vehicle engine cam gaskets and major/minor engine overhaul packs. But In-Ten has many other types of products.Our excellence in quality has been highly recognized among domestic and international vehicle parts manufacturers, as well as among our trade partners. Since its beginning, ITE’s research and development has concentrated on designing and manufacturing motor vehicle parts and utilizing extremely critical production flow management and quality control regimes. ITE has become a highly regarded and trusted vehicle parts supplier for our customers.
Industrial Technology Research Institute (ITRI)
ITRI is committed to driving the development of various industries with its outstanding technology and research abilities in hopes to create economic values and promote social well-being. In addition to playing a role of researcher and developer in the fields of medicine as well as medical devices, it has also established a complete structure of CRO (Contract Research Organizations) and CDMO (Contract Development & Manufacturing Organization) services. The one-stop biomedical services platform of ITRI provides assistance in a wide range of scopes, including research and development, model translation, GXP trial production, pre-clinical/clinical trial, post-marketing consultation, etc. This mechanism makes it possible for domestic manufacturers to lower their initial cost of investment, and accelerate their research and development. ◆ Regulation Consulting: FDA/TFDA/CE application, medical device verification/export, medical device/medicine registration, IRB document organization, clinical trial application, and more. ◆ Licencing: Bio-IT, diagnostics and precision medicine technology, regeneration medicine technology, natural medicine and healthcare technology, targeted drug and delivery technology. ◆ Prototyping: Domestic supply chain linkage, medical device design control, market analysis, strategy analysis of regulation in commercialization, and more. ◆ Preclinical/Clinical Trial: Functional safety assessments, clinical research organization linkage, clinical evaluation and analysis, clinical trial planning, clinical trial analysis and reports. ◆ Other Services: Quality system consulting, commercialization consulting, smart health solutions, software validation, medical device risk management, information security risk evaluation, technical documents preparation, business ecosystem linkage, and more.
ImmunAdd Inc.
Founded in 2021, ImmunAdd, Inc., is a privately held biopharmaceutical company on a mission to improve health through advances in adjuvant design and formulation. We are developing next-generation saponin adjuvants and using them as the basis for new combination adjuvants and adjuvanted vaccines. Our lead adjuvant, IA-05, is a rationally designed analog of the saponin adjuvant QS-21. IA-05 elicits immune responses comparable to or better than QS-21 and is better tolerated and more stable. With IA-05 as the foundation, ImmunAdd is designing adjuvant platforms able to deliver a specific immune response . | Founded in 2021, ImmunAdd, Inc., is a privately held biopharmaceutical company on a mission to improve health through advances in adjuvant design and formulation. | ImmunAdd is a biotech pharmaceutical research and development company focused on drug design and formulation development. Our team members have accumulated years of experience in medicinal chemistry, drug formulation, drug regulations, and biological evaluations. Our pipeline covers vaccine adjuvant development, new formulation development, and novel drug conjugations applied in vaccines, cancer, and immunotherapies. Our lead adjuvant, IA-05, is a rationally designed analog of natural saponin QS-21, and it provides a sustainable source of saponin-based adjuvant. IA-05: a fully synthetic saponin-based vaccine adjuvant that has demonstrated improved tolerability and elicited improved enhanced immune responses compared with QS-21 in influenza, HBV, HPV, and anti-cancer vaccines. IA-05 can therefore enable the development of safer, more effective, and more durable vaccines. IAS-01: a vaccine adjuvant system comprising IA-05 and a synthetic TLR agonist, which is a mimic of AS01. The immunogenicity of antigens can be enhanced synergistically and durably by IAS-01.
ICP Technology Co.,Ltd
Well DPC Design and Manufacturing Experience：The First Ceramic DPC Developing Engineering Team in Taiwan since 1999. ICP is not only a Manufacturing Company but a Design House to strive to provide superior manufacturing service on processing integration for ceramic substrate application.